Related references
Note: Only part of the references are listed.Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort
Norikazu Masuda et al.
EUROPEAN JOURNAL OF CANCER (2022)
Transforming Growth Factor-β: An Agent of Change in the Tumor Microenvironment
Christina H. Stuelten et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
TGF-β Signaling and Resistance to Cancer Therapy
Maoduo Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy
Hans Raskov et al.
FRONTIERS IN ONCOLOGY (2021)
TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer
Ksenia M. Yegodayev et al.
CANCERS (2020)
A selective inference approach for false discovery rate control using multiomics covariates yields insights into disease risk
Ronald Yurko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Radio resistance in breast cancer cells is mediated through TGF-β signalling, hybrid epithelial-mesenchymal phenotype and cancer stem cells
Poonam Yadav et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5
Ziqian Li et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway
Yan-Liang Li et al.
ONCOTARGET (2017)
TGFβ1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer
Junlong Zhuang et al.
THERANOSTICS (2017)
Antitumor effects of eribulin depend on modulation of the tumor microenvironment by vascular remodeling in mouse models
Ken Ito et al.
CANCER SCIENCE (2017)
In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab
Shigeto Ueda et al.
BRITISH JOURNAL OF CANCER (2016)
TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
Naoki Oshimori et al.
CELL (2015)
Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models
Yasuhiro Funahashi et al.
CANCER SCIENCE (2014)
A modified toxicity probability interval method for dose-finding trials
Yuan Ji et al.
CLINICAL TRIALS (2010)
Macrocyclic ketone analogues of halichondrin B
WJ Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)